カテゴリ： 世界, 医療/バイオ, Market Monitor Global

脊髄損傷治療薬のグローバル市場展望 2023年-2029年：経口、静脈内

■ 英語タイトル：Spinal Cord Injury Therapeutic Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8678）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8678
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：119
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[脊髄損傷治療薬のグローバル市場展望 2023年-2029年：経口、静脈内]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の脊髄損傷治療薬市場規模と予測を収録しています。・世界の脊髄損傷治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の脊髄損傷治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の脊髄損傷治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

脊髄損傷治療薬のグローバル主要企業は、Teva Pharmaceutical Industries Ltd.、 AbbVie Inc.、 Pfizer Inc.、 Dr. Reddy's Laboratories Ltd.、 Zydus Cadila、 ReNetX Bio, Inc.、 InVivo Therapeutics Holdings、 Lineage Cell Therapeutics Inc.、 Kringle Pharma, Inc.、 Acorda Therapeutics, Inc.、 Bioaxone Biosciences, Inc.、 RespireRx Pharmaceuticals Inc.、 NervGen、 Rising Pharmaceuticals, Inc.、 ScieGen Pharmaceuticals, Inc.、 MSN Laboratories Private Limited、 Lannett Co Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、脊髄損傷治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の脊髄損傷治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の脊髄損傷治療薬市場：タイプ別市場シェア、2022年
・経口、静脈内

世界の脊髄損傷治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の脊髄損傷治療薬市場：用途別市場シェア、2022年
・病院薬局、小売薬局、オンライン薬局

世界の脊髄損傷治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の脊髄損傷治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における脊髄損傷治療薬のグローバル売上、2018年-2023年
・主要企業における脊髄損傷治療薬のグローバル売上シェア、2022年
・主要企業における脊髄損傷治療薬のグローバル販売量、2018年-2023年
・主要企業における脊髄損傷治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Teva Pharmaceutical Industries Ltd.、 AbbVie Inc.、 Pfizer Inc.、 Dr. Reddy's Laboratories Ltd.、 Zydus Cadila、 ReNetX Bio, Inc.、 InVivo Therapeutics Holdings、 Lineage Cell Therapeutics Inc.、 Kringle Pharma, Inc.、 Acorda Therapeutics, Inc.、 Bioaxone Biosciences, Inc.、 RespireRx Pharmaceuticals Inc.、 NervGen、 Rising Pharmaceuticals, Inc.、 ScieGen Pharmaceuticals, Inc.、 MSN Laboratories Private Limited、 Lannett Co Inc.

*************************************************************

・調査・分析レポートの概要
脊髄損傷治療薬市場の定義
市場セグメント
世界の脊髄損傷治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の脊髄損傷治療薬市場規模
世界の脊髄損傷治療薬市場規模：2022年 VS 2029年
世界の脊髄損傷治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの脊髄損傷治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の脊髄損傷治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：経口、静脈内
脊髄損傷治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院薬局、小売薬局、オンライン薬局
脊髄損傷治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別脊髄損傷治療薬市場規模 2022年と2029年
地域別脊髄損傷治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Teva Pharmaceutical Industries Ltd.、 AbbVie Inc.、 Pfizer Inc.、 Dr. Reddy's Laboratories Ltd.、 Zydus Cadila、 ReNetX Bio, Inc.、 InVivo Therapeutics Holdings、 Lineage Cell Therapeutics Inc.、 Kringle Pharma, Inc.、 Acorda Therapeutics, Inc.、 Bioaxone Biosciences, Inc.、 RespireRx Pharmaceuticals Inc.、 NervGen、 Rising Pharmaceuticals, Inc.、 ScieGen Pharmaceuticals, Inc.、 MSN Laboratories Private Limited、 Lannett Co Inc.
...

Spinal cord injuries (SCI) are the injuries caused to the thirty one pairs of spinal nerves, which carry nerve signals from brain to various parts of the body and also controls the arm and leg movements. The main cause of spinal cord injuries include trauma, loss of blood supply to spinal cord, and compression in spinal cord due to tumor or infections. Spinal cord injuries can be diagnosed with the help of various techniques such as X-ray, magnetic resonance index (MRI), and computed tomography (CT).
This report aims to provide a comprehensive presentation of the global market for Spinal Cord Injury Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spinal Cord Injury Therapeutic. This report contains market size and forecasts of Spinal Cord Injury Therapeutic in global, including the following market information:
Global Spinal Cord Injury Therapeutic Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Spinal Cord Injury Therapeutic Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Spinal Cord Injury Therapeutic companies in 2022 (%)
The global Spinal Cord Injury Therapeutic market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Oral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Spinal Cord Injury Therapeutic include Teva Pharmaceutical Industries Ltd., AbbVie Inc., Pfizer Inc., Dr. Reddy’s Laboratories Ltd., Zydus Cadila, ReNetX Bio, Inc., InVivo Therapeutics Holdings, Lineage Cell Therapeutics Inc. and Kringle Pharma, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Spinal Cord Injury Therapeutic manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Spinal Cord Injury Therapeutic Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Spinal Cord Injury Therapeutic Market Segment Percentages, by Type, 2022 (%)
Oral
Intravenously
Global Spinal Cord Injury Therapeutic Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Spinal Cord Injury Therapeutic Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Spinal Cord Injury Therapeutic Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Spinal Cord Injury Therapeutic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Spinal Cord Injury Therapeutic revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Spinal Cord Injury Therapeutic revenues share in global market, 2022 (%)
Key companies Spinal Cord Injury Therapeutic sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Spinal Cord Injury Therapeutic sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva Pharmaceutical Industries Ltd.
AbbVie Inc.
Pfizer Inc.
Dr. Reddy’s Laboratories Ltd.
Zydus Cadila
ReNetX Bio, Inc.
InVivo Therapeutics Holdings
Lineage Cell Therapeutics Inc.
Kringle Pharma, Inc.
Acorda Therapeutics, Inc.
Bioaxone Biosciences, Inc.
RespireRx Pharmaceuticals Inc.
NervGen
Rising Pharmaceuticals, Inc.
ScieGen Pharmaceuticals, Inc.
MSN Laboratories Private Limited
Lannett Co Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Spinal Cord Injury Therapeutic, market overview.
Chapter 2: Global Spinal Cord Injury Therapeutic market size in revenue and volume.
Chapter 3: Detailed analysis of Spinal Cord Injury Therapeutic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Spinal Cord Injury Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Spinal Cord Injury Therapeutic capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Spinal Cord Injury Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Spinal Cord Injury Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Spinal Cord Injury Therapeutic Overall Market Size
2.1 Global Spinal Cord Injury Therapeutic Market Size: 2022 VS 2029
2.2 Global Spinal Cord Injury Therapeutic Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Spinal Cord Injury Therapeutic Sales: 2018-2029
3 Company Landscape
3.1 Top Spinal Cord Injury Therapeutic Players in Global Market
3.2 Top Global Spinal Cord Injury Therapeutic Companies Ranked by Revenue
3.3 Global Spinal Cord Injury Therapeutic Revenue by Companies
3.4 Global Spinal Cord Injury Therapeutic Sales by Companies
3.5 Global Spinal Cord Injury Therapeutic Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Spinal Cord Injury Therapeutic Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Spinal Cord Injury Therapeutic Product Type
3.8 Tier 1, Tier 2 and Tier 3 Spinal Cord Injury Therapeutic Players in Global Market
3.8.1 List of Global Tier 1 Spinal Cord Injury Therapeutic Companies
3.8.2 List of Global Tier 2 and Tier 3 Spinal Cord Injury Therapeutic Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Spinal Cord Injury Therapeutic Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Intravenously
4.2 By Type – Global Spinal Cord Injury Therapeutic Revenue & Forecasts
4.2.1 By Type – Global Spinal Cord Injury Therapeutic Revenue, 2018-2023
4.2.2 By Type – Global Spinal Cord Injury Therapeutic Revenue, 2024-2029
4.2.3 By Type – Global Spinal Cord Injury Therapeutic Revenue Market Share, 2018-2029
4.3 By Type – Global Spinal Cord Injury Therapeutic Sales & Forecasts
4.3.1 By Type – Global Spinal Cord Injury Therapeutic Sales, 2018-2023
4.3.2 By Type – Global Spinal Cord Injury Therapeutic Sales, 2024-2029
4.3.3 By Type – Global Spinal Cord Injury Therapeutic Sales Market Share, 2018-2029
4.4 By Type – Global Spinal Cord Injury Therapeutic Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Spinal Cord Injury Therapeutic Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application – Global Spinal Cord Injury Therapeutic Revenue & Forecasts
5.2.1 By Application – Global Spinal Cord Injury Therapeutic Revenue, 2018-2023
5.2.2 By Application – Global Spinal Cord Injury Therapeutic Revenue, 2024-2029
5.2.3 By Application – Global Spinal Cord Injury Therapeutic Revenue Market Share, 2018-2029
5.3 By Application – Global Spinal Cord Injury Therapeutic Sales & Forecasts
5.3.1 By Application – Global Spinal Cord Injury Therapeutic Sales, 2018-2023
5.3.2 By Application – Global Spinal Cord Injury Therapeutic Sales, 2024-2029
5.3.3 By Application – Global Spinal Cord Injury Therapeutic Sales Market Share, 2018-2029
5.4 By Application – Global Spinal Cord Injury Therapeutic Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Spinal Cord Injury Therapeutic Market Size, 2022 & 2029
6.2 By Region – Global Spinal Cord Injury Therapeutic Revenue & Forecasts
6.2.1 By Region – Global Spinal Cord Injury Therapeutic Revenue, 2018-2023
6.2.2 By Region – Global Spinal Cord Injury Therapeutic Revenue, 2024-2029
6.2.3 By Region – Global Spinal Cord Injury Therapeutic Revenue Market Share, 2018-2029
6.3 By Region – Global Spinal Cord Injury Therapeutic Sales & Forecasts
6.3.1 By Region – Global Spinal Cord Injury Therapeutic Sales, 2018-2023
6.3.2 By Region – Global Spinal Cord Injury Therapeutic Sales, 2024-2029
6.3.3 By Region – Global Spinal Cord Injury Therapeutic Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Spinal Cord Injury Therapeutic Revenue, 2018-2029
6.4.2 By Country – North America Spinal Cord Injury Therapeutic Sales, 2018-2029
6.4.3 US Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.4.4 Canada Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.4.5 Mexico Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Spinal Cord Injury Therapeutic Revenue, 2018-2029
6.5.2 By Country – Europe Spinal Cord Injury Therapeutic Sales, 2018-2029
6.5.3 Germany Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.5.4 France Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.5.5 U.K. Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.5.6 Italy Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.5.7 Russia Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.5.8 Nordic Countries Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.5.9 Benelux Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Spinal Cord Injury Therapeutic Revenue, 2018-2029
6.6.2 By Region – Asia Spinal Cord Injury Therapeutic Sales, 2018-2029
6.6.3 China Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.6.4 Japan Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.6.5 South Korea Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.6.6 Southeast Asia Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.6.7 India Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Spinal Cord Injury Therapeutic Revenue, 2018-2029
6.7.2 By Country – South America Spinal Cord Injury Therapeutic Sales, 2018-2029
6.7.3 Brazil Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.7.4 Argentina Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Spinal Cord Injury Therapeutic Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Spinal Cord Injury Therapeutic Sales, 2018-2029
6.8.3 Turkey Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.8.4 Israel Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.8.5 Saudi Arabia Spinal Cord Injury Therapeutic Market Size, 2018-2029
6.8.6 UAE Spinal Cord Injury Therapeutic Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Teva Pharmaceutical Industries Ltd.
7.1.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.1.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.1.3 Teva Pharmaceutical Industries Ltd. Spinal Cord Injury Therapeutic Major Product Offerings
7.1.4 Teva Pharmaceutical Industries Ltd. Spinal Cord Injury Therapeutic Sales and Revenue in Global (2018-2023)
7.1.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.2 AbbVie Inc.
7.2.1 AbbVie Inc. Company Summary
7.2.2 AbbVie Inc. Business Overview
7.2.3 AbbVie Inc. Spinal Cord Injury Therapeutic Major Product Offerings
7.2.4 AbbVie Inc. Spinal Cord Injury Therapeutic Sales and Revenue in Global (2018-2023)
7.2.5 AbbVie Inc. Key News & Latest Developments
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Company Summary
7.3.2 Pfizer Inc. Business Overview
7.3.3 Pfizer Inc. Spinal Cord Injury Therapeutic Major Product Offerings
7.3.4 Pfizer Inc. Spinal Cord Injury Therapeutic Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Inc. Key News & Latest Developments
7.4 Dr. Reddy’s Laboratories Ltd.
7.4.1 Dr. Reddy’s Laboratories Ltd. Company Summary
7.4.2 Dr. Reddy’s Laboratories Ltd. Business Overview
7.4.3 Dr. Reddy’s Laboratories Ltd. Spinal Cord Injury Therapeutic Major Product Offerings
7.4.4 Dr. Reddy’s Laboratories Ltd. Spinal Cord Injury Therapeutic Sales and Revenue in Global (2018-2023)
7.4.5 Dr. Reddy’s Laboratories Ltd. Key News & Latest Developments
7.5 Zydus Cadila
7.5.1 Zydus Cadila Company Summary
7.5.2 Zydus Cadila Business Overview
7.5.3 Zydus Cadila Spinal Cord Injury Therapeutic Major Product Offerings
7.5.4 Zydus Cadila Spinal Cord Injury Therapeutic Sales and Revenue in Global (2018-2023)
7.5.5 Zydus Cadila Key News & Latest Developments
7.6 ReNetX Bio, Inc.
7.6.1 ReNetX Bio, Inc. Company Summary
7.6.2 ReNetX Bio, Inc. Business Overview
7.6.3 ReNetX Bio, Inc. Spinal Cord Injury Therapeutic Major Product Offerings
7.6.4 ReNetX Bio, Inc. Spinal Cord Injury Therapeutic Sales and Revenue in Global (2018-2023)
7.6.5 ReNetX Bio, Inc. Key News & Latest Developments
7.7 InVivo Therapeutics Holdings
7.7.1 InVivo Therapeutics Holdings Company Summary
7.7.2 InVivo Therapeutics Holdings Business Overview
7.7.3 InVivo Therapeutics Holdings Spinal Cord Injury Therapeutic Major Product Offerings
7.7.4 InVivo Therapeutics Holdings Spinal Cord Injury Therapeutic Sales and Revenue in Global (2018-2023)
7.7.5 InVivo Therapeutics Holdings Key News & Latest Developments
7.8 Lineage Cell Therapeutics Inc.
7.8.1 Lineage Cell Therapeutics Inc. Company Summary
7.8.2 Lineage Cell Therapeutics Inc. Business Overview
7.8.3 Lineage Cell Therapeutics Inc. Spinal Cord Injury Therapeutic Major Product Offerings
7.8.4 Lineage Cell Therapeutics Inc. Spinal Cord Injury Therapeutic Sales and Revenue in Global (2018-2023)
7.8.5 Lineage Cell Therapeutics Inc. Key News & Latest Developments
7.9 Kringle Pharma, Inc.
7.9.1 Kringle Pharma, Inc. Company Summary
7.9.2 Kringle Pharma, Inc. Business Overview
7.9.3 Kringle Pharma, Inc. Spinal Cord Injury Therapeutic Major Product Offerings
7.9.4 Kringle Pharma, Inc. Spinal Cord Injury Therapeutic Sales and Revenue in Global (2018-2023)
7.9.5 Kringle Pharma, Inc. Key News & Latest Developments
7.10 Acorda Therapeutics, Inc.
7.10.1 Acorda Therapeutics, Inc. Company Summary
7.10.2 Acorda Therapeutics, Inc. Business Overview
7.10.3 Acorda Therapeutics, Inc. Spinal Cord Injury Therapeutic Major Product Offerings
7.10.4 Acorda Therapeutics, Inc. Spinal Cord Injury Therapeutic Sales and Revenue in Global (2018-2023)
7.10.5 Acorda Therapeutics, Inc. Key News & Latest Developments
7.11 Bioaxone Biosciences, Inc.
7.11.1 Bioaxone Biosciences, Inc. Company Summary
7.11.2 Bioaxone Biosciences, Inc. Spinal Cord Injury Therapeutic Business Overview
7.11.3 Bioaxone Biosciences, Inc. Spinal Cord Injury Therapeutic Major Product Offerings
7.11.4 Bioaxone Biosciences, Inc. Spinal Cord Injury Therapeutic Sales and Revenue in Global (2018-2023)
7.11.5 Bioaxone Biosciences, Inc. Key News & Latest Developments
7.12 RespireRx Pharmaceuticals Inc.
7.12.1 RespireRx Pharmaceuticals Inc. Company Summary
7.12.2 RespireRx Pharmaceuticals Inc. Spinal Cord Injury Therapeutic Business Overview
7.12.3 RespireRx Pharmaceuticals Inc. Spinal Cord Injury Therapeutic Major Product Offerings
7.12.4 RespireRx Pharmaceuticals Inc. Spinal Cord Injury Therapeutic Sales and Revenue in Global (2018-2023)
7.12.5 RespireRx Pharmaceuticals Inc. Key News & Latest Developments
7.13 NervGen
7.13.1 NervGen Company Summary
7.13.2 NervGen Spinal Cord Injury Therapeutic Business Overview
7.13.3 NervGen Spinal Cord Injury Therapeutic Major Product Offerings
7.13.4 NervGen Spinal Cord Injury Therapeutic Sales and Revenue in Global (2018-2023)
7.13.5 NervGen Key News & Latest Developments
7.14 Rising Pharmaceuticals, Inc.
7.14.1 Rising Pharmaceuticals, Inc. Company Summary
7.14.2 Rising Pharmaceuticals, Inc. Business Overview
7.14.3 Rising Pharmaceuticals, Inc. Spinal Cord Injury Therapeutic Major Product Offerings
7.14.4 Rising Pharmaceuticals, Inc. Spinal Cord Injury Therapeutic Sales and Revenue in Global (2018-2023)
7.14.5 Rising Pharmaceuticals, Inc. Key News & Latest Developments
7.15 ScieGen Pharmaceuticals, Inc.
7.15.1 ScieGen Pharmaceuticals, Inc. Company Summary
7.15.2 ScieGen Pharmaceuticals, Inc. Business Overview
7.15.3 ScieGen Pharmaceuticals, Inc. Spinal Cord Injury Therapeutic Major Product Offerings
7.15.4 ScieGen Pharmaceuticals, Inc. Spinal Cord Injury Therapeutic Sales and Revenue in Global (2018-2023)
7.15.5 ScieGen Pharmaceuticals, Inc. Key News & Latest Developments
7.16 MSN Laboratories Private Limited
7.16.1 MSN Laboratories Private Limited Company Summary
7.16.2 MSN Laboratories Private Limited Business Overview
7.16.3 MSN Laboratories Private Limited Spinal Cord Injury Therapeutic Major Product Offerings
7.16.4 MSN Laboratories Private Limited Spinal Cord Injury Therapeutic Sales and Revenue in Global (2018-2023)
7.16.5 MSN Laboratories Private Limited Key News & Latest Developments
7.17 Lannett Co Inc.
7.17.1 Lannett Co Inc. Company Summary
7.17.2 Lannett Co Inc. Business Overview
7.17.3 Lannett Co Inc. Spinal Cord Injury Therapeutic Major Product Offerings
7.17.4 Lannett Co Inc. Spinal Cord Injury Therapeutic Sales and Revenue in Global (2018-2023)
7.17.5 Lannett Co Inc. Key News & Latest Developments
8 Global Spinal Cord Injury Therapeutic Production Capacity, Analysis
8.1 Global Spinal Cord Injury Therapeutic Production Capacity, 2018-2029
8.2 Spinal Cord Injury Therapeutic Production Capacity of Key Manufacturers in Global Market
8.3 Global Spinal Cord Injury Therapeutic Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Spinal Cord Injury Therapeutic Supply Chain Analysis
10.1 Spinal Cord Injury Therapeutic Industry Value Chain
10.2 Spinal Cord Injury Therapeutic Upstream Market
10.3 Spinal Cord Injury Therapeutic Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Spinal Cord Injury Therapeutic Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 脊髄刺激装置のグローバル市場展望 2023年-2029年：充電式、非充電式
  • 髄液圧測定用マノメーターのグローバル市場展望 2023年-2029年：一体型、分離型
  • 世界の脊髄刺激（SCS）システム市場2022年：市場規模予測（～2028年）
  • 世界の脊髄刺激装置（SCS）装置市場2022年：市場規模予測（～2028年）
  • ジカウイルス治療薬のグローバル市場展望 2023年-2029年：アセトアミノフェン、その他のNSAIDs
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8678 )"脊髄損傷治療薬のグローバル市場展望 2023年-2029年：経口、静脈内" (英文：Spinal Cord Injury Therapeutic Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。